The Longevity Business Is Booming—and Its Scientists Are Clashing
The antiaging movement has raced ahead amid fierce debates over even its earliest theories. Critics of a grandfather of the ...
Lam Research (NASDAQ:LRCX) Earns Outperform Rating from Analysts at Oppenheimer
Oppenheimer began coverage on shares of Lam Research (NASDAQ:LRCX – Free Report) in a research report released on Thursday morning. The brokerage issued an outperform rating and a $95.00 target price ...